
Detects & neutralizes tinnitus parameters for each individual.

Live therapy adjusts to patient’s auditory feedback.

From objective assessment to personalized all treatment.

Fulfilling a desperate global demand for objective tinnitus relief.

Patent‑protected tech building a strong barrier to competitors.
OUR MISSION
To transform the lives of millions affected by tinnitus through an intelligent, non-invasive, and truly personalized solution.
At WonderBrAIn, we are committed to delivering a breakthrough platform that uses AI-driven diagnosis and real-time therapy to bring relief—anytime, anywhere. Our mission is to replace frustration and helplessness with clarity and control by providing scalable, clinically proven, and user-friendly tinnitus care.
We aim to set a new global standard for how tinnitus is understood, managed, and ultimately improved—one patient at a time.
Our Vision
To redefine the way the world understands, diagnoses, and treats tinnitus.
At WonderBrAIn, we envision a future where no one has to live in silence—or with it. A future where technology bridges the gap between suffering and relief through intelligent, real-time solutions. Our mission is not just to manage tinnitus, but to empower individuals with a personalized, accessible, and scientifically validated path to reclaim control over their auditory world.
We believe that precision medicine, driven by artificial intelligence and human-centered design, can transform tinnitus care from a fragmented experience into a seamless, effective, and life-changing journey.
Reclaim your silence. Restore your quality of life.
The Problem
Tinnitus: A Silent Epidemic
Over 1.2 billion people globally suffer from tinnitus—persistent, phantom noise with no known cure. Traditional solutions are subjective, inconsistent, and often ineffective. The global market lacks an objective, scalable, and personalized treatment.
Our Solution
AI-Powered Precision Tinnitus Therapy
1. Accurate AI Diagnosis
Our proprietary algorithm detects the unique tinnitus parameters of each patient. Conducted in collaboration with global ENT and audiology clinics, we integrate seamlessly into existing infrastructure.
2. Real-Time Personalized Therapy
Using diagnostic insights, WonderBrAIn delivers live, custom-tailored treatment via a compact, non-invasive MINI device. The result: 24/7 relief, anywhere the patient goes.
This is the first end-to-end platform combining objective diagnostics with real-time, scalable therapy.
Tinnitus Customization
The unique solution is the ability to measure the patient tinnitus frequency parameters through the ear canal and then program it off-line in a standard (Gen I) or in a modified (Gen II) hearing aid device.

TINNITUS DISORDER BACKGROUND
- Tinnitus is a hearing disorder consisting of a continuous phantom acoustical twitter generated by the brain
It appears during day and night at: - A certain constant frequency, but different from person to person
- A different intensity levels
- It causes severe suffer to the sick person
- It is caused by long exposure to high noise levels or by aging

Market Opportunity
An Untapped $Billions Market
- 1.2B+ potential patients worldwide
- Tinnitus-related costs in the hundreds of billions annually
- Driven by aging populations, rising noise exposure, and health awareness
- WonderBrAIn offers the first scalable, precision-based solution to meet this unmet demand

Business Model
- Diagnostic Revenue: Fees from AI-based detection through ENT clinic network
- Recurring Revenue: Device sales + SaaS subscriptions for personalized therapy
- B2B2C Partnerships: ENT clinics as diagnostic and distribution partners
- Global Distribution: Medical device partnerships for fast market penetration
- DTC Expansion: Future consumer-facing model post regulatory clearance

Technology Validation, TNP™ Technology: Clinically Proven
- Tested on 120+ patients
- Consistently accurate tinnitus signal detection
- Validated therapeutic relief and noise cancellation
- De-risked development & regulatory pathway
- Basis for 510(k) FDA and CE applications
THE LEADING TEAM
-
Nahum Cohen M.Sc.
Founder & CTO
-
Dr. Shimon Mizrahi (Ph.D.)
VP R&D
-
Dr. Yehonatan Roth (Ph.D.)
Chief Medical & Clinical Officer
-
Moshe Kamar
Chairman
-
Mira Peled, PhD
Board member
-
Shahar Resman
VP Business Development